Evidence map›Paper›PMID 21536073›Full record

ArticleJournal of virological methods2011

Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.

Steven A Yukl, Peilin Li, Katsuya Fujimoto, Harry Lampiris, Chuanyi M Lu, C Bradley Hare, Steven G Deeks, Teri Liegler, Mark Pandori, Diane V Havlir and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of virological methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The Alphabet Soup of HIV Reservoir Markers.Current HIV/AIDS reports · 2017
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Steven A YuklSan Francisco VA Medical Center, San Francisco, CA 94121, USA. steven.yukl@ucsf.edu
Peilin Li
Katsuya Fujimoto
Harry Lampiris
Chuanyi M Lu
C Bradley Hare
Steven G Deeks
Teri Liegler
Mark Pandori
Diane V Havlir
Joseph K Wong
University of California, San Francisco · USSan Francisco VA Medical Center · USSan Francisco Department of Public Health · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER W HUNT · 1988 to 2026
$93.6M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
HIV-1 Adaptation in the Central Nervous SystemR01NS051132 · NINDS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WONG, JOSEPH K · 2005 to 2009
$1.8M
Therapeutic Strategies for HIV DiseaseK24AI051982 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2002 to 2012
$1.3M
Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV SubtypeR21MH083573 · NIMH · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI WONG, JOSEPH K · 2008 to 2009
$407k
Quantification of HIV-1 Reservoirs in the GutK23AI089397 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YUKL, STEVEN A · 2010 to 2010
$125k
Quantification of HIV Reservoirs in the Gut-Associated Lymphatic SystemIK2CX000520 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI YUKL, STEVEN A · 2011 to 2015
–
CSRD VA IK2 CX000520NIAID NIH HHS 1K23AI089397NIAID NIH HHS K23 AI089397NIAID NIH HHS K24 AI051982NIAID NIH HHS P30 AI027763NIAID NIH HHS P30-AI027763NIAID NIH HHS T32 AI060530NIAID NIH HHS T32 AI60530NIAID NIH HHS UM1 AI069496NIMH NIH HHS R21 MH083573NINDS NIH HHS NS051145NINDS NIH HHS R01 NS051132
6 · The paper itself

Abstract

Although commercial tests are approved for detection of HIV-1 plasma viral loads ≥ 20 copies per milliliter (ml), only one specialized research assay has been reported to detect plasma viral loads as low as 1 copy/ml. This manuscript describes a method of concentrating HIV-1 virions from up to 30 ml of plasma, which can be combined with a commercial viral load test to create a widely available, reproducible assay for quantifying plasma HIV RNA levels less than 1 copy/ml. Using this pre-analytically modified assay, samples with a known level of 0.5 copy/ml were detected in 8 of 12 replicates (mean 0.47 copy/ml; 95% confidence interval (CI) 0.14-0.81 copy/ml) and samples with a known level of 1.0 copy/ml were detected in 13 of 13 replicates (mean 1.96 copy/ml; 95% CI 1.42-2.50 copy/ml). By concentrating virus from 30 ml of plasma, HIV RNA could be measured in 16 of 19 samples (84%) from 12 of 12 subjects (mean 2.77 copy/ml; 95% CI 0.86-4.68 copy/ml). The measured viral load correlated inversely (r = -0.78; p = 0.028) with the total duration of viral suppression (viral load<40 copies/ml).

Indexed as

AdultHIV-1HIV InfectionsHumansMolecular Diagnostic TechniquesPlasmaReproducibility of ResultsRNA, ViralSensitivity and SpecificitySpecimen HandlingViral LoadRNA, Viral

Identifiers

PMID21536073
PMCPMC3827908
OpenAlexW1976785834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.